Investors who lost money on DexCom, Inc.(DXCM) should contact The Gross Law Firm about pending Class Action – DXCM

Investors who lost money on DexCom, Inc.(DXCM) should contact The Gross Law Firm about pending Class Action – DXCM GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class […]

The Gross Law Firm Reminds Avantor, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 29, 2025 – AVTR

The Gross Law Firm Reminds Avantor, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 29, 2025 – AVTR GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR). Shareholders who purchased

CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies

CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells GlobeNewswire December 17, 2025 Lehi, Utah, Dec. 17, 2025 (GLOBE NEWSWIRE) — Lehi, Utah, December 17, 2025 – CancerVax, Inc., the developer of a breakthrough

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 23, 2025 in James Hardie Industries plc. Lawsuit – JHX

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 23, 2025 in James Hardie Industries plc. Lawsuit – JHX GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased

Shareholders of Integer Holdings Corporation Should Contact The Gross Law Firm Before February 9, 2026 to Discuss Your Rights – ITGR

Shareholders of Integer Holdings Corporation Should Contact The Gross Law Firm Before February 9, 2026 to Discuss Your Rights – ITGR GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Integer Holdings Corporation (NYSE: ITGR). Shareholders who purchased shares of ITGR

STUB IPO LAWSUIT DEADLINE: Hagens Berman Urges StubHub Investors to Act by Jan. 23 Over 143% Free Cash Flow Collapse

Partner Reed Kathrein: IPO Prospectus Scrutiny Centers on Alleged Concealment of Adverse Vendor Payment Trends National shareholder rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against StubHub Holdings, Inc. (NYSE: STUB) is January 23, 2026. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The lawsuit

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, announced today that the company will be hosting in-person one-on-one meetings coinciding with the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026. Rick Stewart, Chief

Methode Electronics’ Board Approves Dividend

(NYSE:MEI), CHICAGO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced today that its board of directors has declared a quarterly dividend of $0.05 per share to be paid on January 30, 2026, to common stockholders of

SKYE LAWSUIT ALERT: The Gross Law Firm Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

(NasdaqGM:SKYE), NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

Scroll to Top